The epidemiology of carbapenemases in Latin America and the Caribbean

Expert Review of Anti-infective Therapy
Kevin Escandón-VargasMaria Virginia Villegas

Abstract

Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp. infections are major causes of morbidity and mortality, especially due to the emergence and spread of β-lactamases. Carbapenemases, which are β-lactamases with the capacity to hydrolyze or inactivate carbapenems, have become a serious concern as they have the largest hydrolytic spectrum and therefore limit the utility of most β-lactam antibiotics. Areas covered: Here, we present an update of the current status of carbapenemases in Latin America and the Caribbean. Expert commentary: The increased frequency of reports on carbapenemases in Latin America and the Caribbean shows that they have successfully spread and have even become endemic in some countries. Countries such as Brazil, Colombia, Argentina, and Mexico account for the majority of these reports. Early suspicion and detection along with implementation of antimicrobial stewardship programs in all healthcare settings are crucial for the control and prevention of carbapenemase-producing bacteria.

References

Jan 1, 1991·Antimicrobial Agents and Chemotherapy·M WatanabeS Mitsuhashi
Jul 1, 1995·Antimicrobial Agents and Chemotherapy·Y ArakawaM Ohta
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·T Naas, P Nordmann
Sep 1, 1995·The Journal of Antimicrobial Chemotherapy·W ScaifeS G Amyes
May 19, 2000·Antimicrobial Agents and Chemotherapy·G BouJ Martínez-Beltrán
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G CornagliaR Fontana
Aug 15, 2001·Antimicrobial Agents and Chemotherapy·L PoirelP Nordmann
May 23, 2002·Antimicrobial Agents and Chemotherapy·R BonnetJ Sirot
Feb 8, 2003·Diagnostic Microbiology and Infectious Disease·Ana C GalesHélio S Sader
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Vivi MiriagouJean M Whichard
Jul 5, 2003·Journal of Clinical Microbiology·Libera M Dalla-CostaNeil Woodford
Sep 12, 2003·Emerging Infectious Diseases·Sudha PottumarthyThomas R Fritsche
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Marcela RadiceJuan A Ayala
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·Rodrigo E MendesUNKNOWN SENTRY Antimicrobial Surveillance Program
May 12, 2004·FEMS Microbiology Letters·Sofia VourliLeonidas S Tzouvelekis
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Dec 29, 2004·International Journal of Antimicrobial Agents·Helio S SaderRonald N Jones
Jan 7, 2005·Journal of Clinical Microbiology·Nilton LincopanElsa M Mamizuka
Jan 15, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S BrownS G B Amyes
Jan 15, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H S SaderA C Gales
Jul 21, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas R FritscheRonald N Jones
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Claire HéritierPatrice Nordmann
Oct 12, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·V Viana VieiraA C Paulo Vincente
Oct 22, 2005·The Journal of Antimicrobial Chemotherapy·Alexandre Prehn ZavasckiAfonso Luís Barth
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Maria Virginia VillegasUNKNOWN Colombian Nosocomial Resistance Study Group
Jan 27, 2006·Antimicrobial Agents and Chemotherapy·Juliana CoelhoDavid Livermore
Apr 25, 2006·FEMS Microbiology Letters·Jane F TurtonTyrone L Pitt
Jun 9, 2006·Microbiology and Molecular Biology Reviews : MMBR·Mark A TolemanTimothy R Walsh
Jun 30, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Maria C B TognimHélio S Sader
Jul 18, 2006·International Journal of Antimicrobial Agents·Andrea Karina Merkier, Daniela Centrón
Jul 28, 2006·Antimicrobial Agents and Chemotherapy·Maria Virginia VillegasUNKNOWN Colombian Nosocomial Resistance Study Group

❮ Previous
Next ❯

Citations

Jun 2, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Adriana CorreaMaría V Villegas
Feb 24, 2018·The Pediatric Infectious Disease Journal·Mónica CerezalesLucía Gallego
Jan 25, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Isadora Rodrigues da SilvaCláudio Marcos Rocha-de-Souza
Feb 23, 2019·Journal of the Pediatric Infectious Diseases Society·Pranita D Tamma, Alice J Hsu
Aug 30, 2019·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·V PappZ Illes
Mar 25, 2020·Microorganisms·José E VillacísMónica C Gestal
Apr 4, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Max M FeinsteinMaría V Villegas
Feb 15, 2018·Physical Chemistry Chemical Physics : PCCP·Juan DuanZuguo Zhao
Jul 17, 2019·Emerging Infectious Diseases·Rita RojasAnne-Catrin Uhlemann
Sep 19, 2019·Biomédica : revista del Instituto Nacional de Salud·Ana Mercedes RadaMaria Virginia Villegas
Sep 26, 2020·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Dianny MartínezMarcos De Donato
Jan 22, 2019·Frontiers in Microbiology·Laís Calissi Brisolla TavaresCarlos Henrique Camargo
Jul 25, 2019·Antibiotics·Tatiana PachecoJavier Escobar-Perez
Sep 26, 2020·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Eddie Angles-YanquiLuis Pampa-Espinoza
May 15, 2020·Clinical Microbiology Reviews·David M P De OliveiraMark J Walker
Aug 20, 2020·Expert Review of Anti-infective Therapy·Juan Carlos García-BetancurMaría Virginia Villegas
Aug 9, 2020·Scientific Reports·Ana Paula Barbosa do NascimentoFabrício Alves Barbosa da Silva
Nov 29, 2020·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Marcela França DiasAndréa Maria Amaral Nascimento
Apr 9, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Rodolfo E QuirósUNKNOWN PROA-LATAM Project Group
May 26, 2021·Antimicrobial Agents and Chemotherapy·Erin K McCrearyPranita D Tamma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.